Hallucinogen actions on human brain revealed

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 6, 2012, Pages 1820-1821

  Lee, Hyeong Min ^a   Roth, Bryan L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSERGIC ACID; PLACEBO; PSILOCIN; PSILOCYBINE; PSYCHEDELIC AGENT; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST;

BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN REGION; CELL ACTIVITY; CONSCIOUSNESS DISORDER; DRUG MECHANISM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROTRANSMISSION; NONHUMAN; NOTE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SPIN LABELING; THALAMUS; TIME PERCEPTION; VISION;

BRAIN; FEMALE; HALLUCINOGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSILOCYBINE;

EID: 84863175284     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121358109     Document Type: Note

References (14)

1. Roth BL, et al. (2002) Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939. (Pubitemid 34994502)
2. Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505-2511. (Pubitemid 15212191)
3. González-Maeso J, et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439-452. (Pubitemid 46161267)
4. Keiser MJ, et al. (2009) Predicting new molecular targets for known drugs. Nature 462:175-181.
5. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902. (Pubitemid 29189323)
6. Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37:630-640.
7. Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599. (Pubitemid 27272104)
8. Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (2007) Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci USA 104:9870-9875. (Pubitemid 47175358)
9. Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735-740.
10. Willins DL, Deutch AY, Roth BL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27:79-82. (Pubitemid 27327604)
11. de Almeida J, Mengod G (2007) Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J Neurochem 103:475-486.
12. Puig MV, Watakabe A, Ushimaru M, Yamamori T, Kawaguchi Y (2010) Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J Neurosci 30:2211-2222.
13. Weber ET, Andrade R (2010) Htr2a gene and 5-HT(2A) receptor expression in the cerebral cortex studied using genetically modified mice. Front Neurosci 4.
14. Carhart-Harris RL, et al. (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA 109:2138-2143.